Two New TB Reports from TAG
The Treatment Action Group has released two new reports on tuberculosis, both valuable resources in the effort to combat this global TB epidemic. The first report details the level of global funding...
View ArticleNew MDR-TB Study Highlights the Promise of R&D in Fight Against Deadly Bug
In a small new study, researchers found that linezolid, an antibiotic first approved in 2000, may be an effective component in the treatment of multidrug-resistant drug-resistant tuberculosis. But as...
View ArticlePublic and Private Sector Partners Help to Jump Start Development of New TB...
This post is by Global Center Director Christine Lubinski. The excitement in the room was palatable today as FDA Commissioner Margaret Hamburg joined representatives from the Global Alliance for TB...
View ArticleThe PDP+ Fund: Accelerating R&D in New Products for Diseases of Poverty
This guest blog about innovative financing for global health was written by Holly Wong, vice president for public policy at the International AIDS Vaccine Initiative; Dr. Mary Moran, director of health...
View ArticleCollaboration seeks to speed new TB treatments
About half a century has passed since a new tuberculosis drug was put to use, and in that time the challenges to successful treatment of the disease have only grown, with bacteria adapting faster to...
View Article
